Tuberculosis, COVID-19, and the End Tuberculosis strategy in India
- PMID: 33154206
- PMCID: PMC7879868
- DOI: 10.4103/lungindia.lungindia_544_20
Tuberculosis, COVID-19, and the End Tuberculosis strategy in India
Conflict of interest statement
None
References
-
- COVID-19 Dash Board by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) and Official Updates Coronavirus-COVID-19 in India. [[Last accessed on 2020 Jul 01]]. Available from: https://mygovin .
-
- Liu Y, Bi L, Chen Y, Wang Y, Fleming J, Yu Y, et al. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. medRxiv. 2020 [doi: 101101/2020031020033795]
-
- Pathak L, Gayan S, Pal B, Talukdar J, Bhuyan S, Sandhya S, et al. Corona virus activates a stem cell mediated defence mechanism that accelerates activation of dormant tuberculosis: Implications for the covid-19 pandemic bioRxiv. 2020. Available from: https://wwwbiorxivorg/content/101101/20200506077883v1 .
-
- Global Tuberculosis Report 2019. Geneva: World Health Organization; 2019.
-
- India TB Report 2020; National Tuberculosis Elimination Program Annual Report. New Delhi: Central TB Division Ministry of Health and Family Welfare, Nirman Bhawan; 2020. [ [Last accessed on 2020 Sep 23]]. Available from: http://wwwtbcindiagovin .
Publication types
LinkOut - more resources
Full Text Sources
